Duquesne Family Office LLC / CRNX
Duquesne Family Office LLC’s Crinetics Pharmaceuticals In Position
Does Duquesne Family Office LLC own Crinetics Pharmaceuticals In (CRNX)? Not currently — the last reported position was 122.7K shares worth $6M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$6M
Q4 2024
Shares
122.7K
% of Portfolio
+0.17%
Quarters Held
4
position exited
Position History CRNX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of CRNX.